BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16335981)

  • 1. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
    Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK
    J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric identification of serum peptides employing derivatized poly(glycidyl methacrylate/divinyl benzene) particles and mu-HPLC.
    Rainer M; Najam-ul-Haq M; Bakry R; Huck CW; Bonn GK
    J Proteome Res; 2007 Jan; 6(1):382-6. PubMed ID: 17203982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM; Pitts RL
    Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-fast mass fingerprinting by high-affinity capture of peptides and proteins on derivatized poly(glycidyl methacrylate/divinylbenzene) for the analysis of serum and cell lysates.
    Rainer M; Muhammad NU; Huck CW; Feuerstein I; Bakry R; Huber LA; Gjerde DT; Zou X; Qian H; Du X; Wei-Gang F; Ke Y; Bonn GK
    Rapid Commun Mass Spectrom; 2006; 20(19):2954-60. PubMed ID: 16953521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemically modified diamond-like carbon (DLC) for protein enrichment and profiling by MALDI-MS.
    Najam-ul-Haq M; Rainer M; Huck CW; Ashiq MN; Bonn GK
    Amino Acids; 2012 Aug; 43(2):823-31. PubMed ID: 22080208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
    Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
    Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(glycidyl methacrylate/divinylbenzene)-IDA-FeIII in phosphoproteomics.
    Aprilita NH; Huck CW; Bakry R; Feuerstein I; Stecher G; Morandell S; Huang HL; Stasyk T; Huber LA; Bonn GK
    J Proteome Res; 2005; 4(6):2312-9. PubMed ID: 16335980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
    Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
    J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicolumn separation platform for simultaneous depletion and prefractionation prior to 2-DE for facilitating in-depth serum proteomics profiling.
    Jmeian Y; El Rassi Z
    J Proteome Res; 2009 Oct; 8(10):4592-603. PubMed ID: 19670910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the matrix structure and concentration of polymer-immobilized Ni2+-iminodiacetic acid complexes on retention of IgG1.
    Krácalíková K; Tishchenko G; Bleha M
    J Biochem Biophys Methods; 2006 Apr; 67(1):7-25. PubMed ID: 16466797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum protein profiling by miniaturized solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Mohammed S; Bunkenborg J; Kruse TA; Cold S; Mogensen O; Christensen Rd; Vach W; Jørgensen PE; Jensen ON
    Rapid Commun Mass Spectrom; 2005; 19(12):1578-86. PubMed ID: 15915448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new analytical material-enhanced laser desorption ionization (MELDI) based approach for the determination of low-mass serum constituents using fullerene derivatives for selective enrichment.
    Vallant RM; Szabo Z; Trojer L; Najam-ul-Haq M; Rainer M; Huck CW; Bakry R; Bonn GK
    J Proteome Res; 2007 Jan; 6(1):44-53. PubMed ID: 17203947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
    J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
    Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
    Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.